NO902995L - Stabilisert fgf sammensetning samt fremstilling derav. - Google Patents

Stabilisert fgf sammensetning samt fremstilling derav.

Info

Publication number
NO902995L
NO902995L NO90902995A NO902995A NO902995L NO 902995 L NO902995 L NO 902995L NO 90902995 A NO90902995 A NO 90902995A NO 902995 A NO902995 A NO 902995A NO 902995 L NO902995 L NO 902995L
Authority
NO
Norway
Prior art keywords
fgf protein
stabilized
composition
manufacturing
water
Prior art date
Application number
NO90902995A
Other languages
English (en)
Other versions
NO902995D0 (no
Inventor
Yohko Akiyama
Minoru Yoshioka
Nobuyuki Kitamori
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO902995D0 publication Critical patent/NO902995D0/no
Publication of NO902995L publication Critical patent/NO902995L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
NO90902995A 1989-07-07 1990-07-04 Stabilisert fgf sammensetning samt fremstilling derav. NO902995L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17622889 1989-07-07
JP13633390 1990-05-24

Publications (2)

Publication Number Publication Date
NO902995D0 NO902995D0 (no) 1990-07-04
NO902995L true NO902995L (no) 1991-01-08

Family

ID=26469955

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902995A NO902995L (no) 1989-07-07 1990-07-04 Stabilisert fgf sammensetning samt fremstilling derav.

Country Status (14)

Country Link
US (1) US5189148A (no)
EP (1) EP0406856B1 (no)
JP (1) JP2536247B2 (no)
CN (1) CN1049106A (no)
AT (1) ATE102044T1 (no)
AU (1) AU632344B2 (no)
CA (1) CA2020654A1 (no)
DE (1) DE69006947T2 (no)
DK (1) DK0406856T3 (no)
ES (1) ES2062206T3 (no)
FI (1) FI903440A7 (no)
HU (1) HU205862B (no)
IE (1) IE902470A1 (no)
NO (1) NO902995L (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5202311A (en) * 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
GB9015824D0 (en) * 1990-07-18 1990-09-05 Erba Carlo Spa Stable pharmaceutical compositions containing a fibroblast growth factor
US5714458A (en) * 1990-07-18 1998-02-03 Farmitalia Carlo Erba S.R.L. Stable pharmaceutical compositions containing a fibroblast growth factor
US5500409A (en) * 1990-10-01 1996-03-19 Thomas Jefferson University Method for inhibiting collagen synthesis by keloid fibroblasts
TW209174B (no) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
AU664561B2 (en) 1991-06-21 1995-11-23 University Of Cincinnati, The Orally administrable therapeutic proteins and method of making
DE4121043A1 (de) * 1991-06-26 1993-01-07 Merck Patent Gmbh Knochenersatzmaterial mit fgf
CA2080537A1 (en) * 1991-10-21 1993-04-22 David B. Volkin Stabilized topical acidic fibroblast growth factor formulation
CA2080538A1 (en) * 1991-10-21 1993-04-22 Joseph V. Bondi Lyophilized acidic fibroblast growth factor
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5482929A (en) * 1991-12-26 1996-01-09 Kaken Pharmaceutical Co., Ltd. Composition of stabilized fibroblast growth factor
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5348941A (en) * 1992-04-01 1994-09-20 Merck & Co., Inc. Stabilizers for fibroblast growth factors
SE9201073D0 (sv) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
DE4242889A1 (de) * 1992-12-18 1994-06-23 Merck Patent Gmbh Hohlendoprothesen mit Knochenwachstumsfördernder Füllung
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
US5331095A (en) * 1993-04-12 1994-07-19 Scios Nova Inc. Process for purification of basic fibroblast growth factor
JP3639593B2 (ja) * 1993-05-31 2005-04-20 科研製薬株式会社 塩基性線維芽細胞増殖因子含有架橋ゼラチンゲル製剤
TW282403B (no) * 1993-08-26 1996-08-01 Takeda Pharm Industry Co Ltd
CN1228708A (zh) * 1996-09-04 1999-09-15 有限会社多特 经口给药用含肽药物组合物
US6692961B1 (en) * 1996-10-11 2004-02-17 Invitrogen Corporation Defined systems for epithelial cell culture and use thereof
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
AU4912100A (en) * 1999-06-07 2000-12-28 Fibersugar Aps Particulate fibre composition
US20030228288A1 (en) 1999-10-15 2003-12-11 Scarborough Nelson L. Volume maintaining osteoinductive/osteoconductive compositions
YU43702A (sh) 1999-12-23 2004-11-25 Pfizer Products Inc. Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US9387094B2 (en) 2000-07-19 2016-07-12 Warsaw Orthopedic, Inc. Osteoimplant and method of making same
US7323193B2 (en) 2001-12-14 2008-01-29 Osteotech, Inc. Method of making demineralized bone particles
EP1434608B1 (en) 2001-10-12 2018-08-22 Warsaw Orthopedic, Inc. Improved bone graft
FR2836011B1 (fr) * 2002-02-20 2004-05-14 Goemar Lab Sa Agent pour la stimulation des defenses naturelles des plantes et procede pour sa mise en oeuvre
KR100981443B1 (ko) * 2002-04-01 2010-09-13 가켄 세야쿠 가부시키가이샤 염기성 선유 아세포 증식 인자 함유 치과용 점조 제제
NZ544050A (en) 2003-06-11 2009-03-31 Osteotech Inc Osteoimplants and methods for their manufacture
EP2335650B1 (en) 2003-12-11 2012-10-03 Isto Technologies Inc. Particulate cartilage system
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
JP5292533B2 (ja) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド インプラントおよび関節疾患の治療、置換および治療方法
WO2007056671A1 (en) 2005-11-02 2007-05-18 Osteotech, Inc. Hemostatic bone graft
US20080154233A1 (en) * 2006-12-20 2008-06-26 Zimmer Orthobiologics, Inc. Apparatus for delivering a biocompatible material to a surgical site and method of using same
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
EP2134297B1 (en) * 2007-04-12 2017-03-08 Zimmer, Inc. Apparatus for tissue repair
US8722075B2 (en) 2008-10-24 2014-05-13 Warsaw Orthopedic, Inc. Compositions and methods for promoting bone formation
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
SG10201706813WA (en) * 2012-03-30 2017-10-30 Ajinomoto Kk Culture medium for proliferating stem cell, which contains sulfated compound
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
US11746135B2 (en) 2015-11-27 2023-09-05 Masarykova Univerzita Thermostable FGF2 polypeptide, use thereof
JP2021138648A (ja) * 2020-03-04 2021-09-16 武田薬品工業株式会社 経口固形製剤
EP4183796A1 (en) 2021-11-19 2023-05-24 Enantis s.r.o. Thermostable fgf10 polypeptide or fragment thereof use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717717A (en) * 1986-11-05 1988-01-05 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
NZ222413A (en) * 1986-11-05 1991-06-25 Ethicon Inc Compositions containing a polypeptide growth factor and a water-soluble cellulose polymer stabiliser
JP2526965B2 (ja) * 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン,dnaおよびその用途
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor

Also Published As

Publication number Publication date
DE69006947D1 (de) 1994-04-07
HU904116D0 (en) 1990-12-28
NO902995D0 (no) 1990-07-04
ATE102044T1 (de) 1994-03-15
FI903440A0 (fi) 1990-07-06
US5189148A (en) 1993-02-23
AU5879990A (en) 1991-01-10
FI903440A7 (fi) 1991-01-08
JP2536247B2 (ja) 1996-09-18
EP0406856A2 (en) 1991-01-09
DK0406856T3 (da) 1994-07-04
IE902470A1 (en) 1991-02-13
EP0406856A3 (en) 1991-04-10
HU205862B (en) 1992-07-28
AU632344B2 (en) 1992-12-24
JPH04128239A (ja) 1992-04-28
EP0406856B1 (en) 1994-03-02
ES2062206T3 (es) 1994-12-16
DE69006947T2 (de) 1994-08-25
CN1049106A (zh) 1991-02-13
HUT54895A (en) 1991-04-29
CA2020654A1 (en) 1991-01-08

Similar Documents

Publication Publication Date Title
AU632344B2 (en) Stabilized fgf composition and production thereof
SE9002522L (sv) Metod foer framstaellning av en farmaceutisk komposition i form av mikropartiklar
ZA907338B (en) Thienylcarboxylates of amino alcohols
ES2111579T3 (es) Preparaciones de factor viii estabilizadas.
NO892217D0 (no) Manoevreringsanordning for lasteskuffe.
AR244674A1 (es) Procedimiento para preparar derivados de acidos 3,4-dihidro-3-tioxo-2h-1,4-bensoxa (o tia)zin-4-aceticos.
NO892099L (no) Anvendelse av 1,1,1,4,4,4-heksafluorbutan som driv- og demmegass for fremstilling av plastskumstoffer.
ATE116524T1 (de) Nematozide zubereitungen.
AU1562988A (en) DNA clone of human thrombomodulin
BG37376A3 (en) Method for preparing salts of benzothiazine dioxide
DE59006688D1 (de) Substituierte Aminosäureamid-Derivate, deren Herstellung und Verwendung.
DE3886936D1 (de) 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG.
EP0254239A3 (en) Optically pure 1,3-dioxenones, methods for preparing same and use thereof
DE69018816D1 (de) Aminosäurederivate.
DE69104299D1 (de) Verfahren zur Herstellung von 2,6-Di-t-butyl-4-merkaptophenol.
AU6764790A (en) 13-beta-phenethylthio-milbemycin derivatives
FI875787A7 (fi) Foerfarande foer framstaellning av lipofila aminosyraderivat, samt lipofila aminosyraderivat.
NO905244D0 (no) Fremgangsmaate for fremstilling av des(64,65)-proinsulin.
DE69009651D1 (de) Verfahren zur Herstellung von 3,4-Dihydrocumarinderivaten.
NO880088D0 (no) 2,1-benzotiazepin-2,2-dioksyd-5-karboksylsyrederivater.
DE3869895D1 (de) Cephalosporinderivate mit verbesserter pharmakokinetik, verfahren zur ihrer herstellung, sie enthaltende pharmazeutische praeparate und zwischenverbindung.
IT8619653A0 (it) Procedimento per la produzione di bussole a struttura perfezionara, per l'unione di parti in legno.
ATE102207T1 (de) 1,1-dioxo-cephem-4-carbothiolsaeure-derivate.
FI892339L (fi) Foerfarande foer framstaellning av 3/4-brom-2-fluorfenyl) metyl/-3,4-dihydro-4-oxo-1-ftalazinaettiksyra.
NO901860D0 (no) Innkapslet syresammensetning samt fremgangsmaate for fremstilling av slik syresammensetning.